Baader Bank Aktiengesellschaft’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,539
Closed -$487K 495
2025
Q3
$487K Buy
1,539
+646
+72% +$201K 0.03% 276
2025
Q2
$345K Buy
+893
New +$359K 0.02% 343
2024
Q4
Sell
-1,710
Closed -$883K 415
2024
Q3
$883K Sell
1,710
-9,327
-85% -$4.98M 0.05% 191
2024
Q2
$5.98M Buy
11,037
+3,939
+55% +$2.08M 0.38% 85
2024
Q1
$3.68M Buy
+7,098
New +$3.53M 0.26% 84
2023
Q3
Sell
-1,427
Closed -$630K 371
2023
Q2
$630K Buy
1,427
+37
+3% +$17.1K 0.03% 220
2023
Q1
$639K Sell
1,390
-600
-30% -$286K 0.03% 228
2022
Q4
$1.02M Sell
1,990
-650
-25% -$330K 0.05% 189
2022
Q3
$1.2M Buy
2,640
+800
+43% +$383K 0.08% 190
2022
Q2
$888K Sell
1,840
-21,710
-92% -$10.7M 0.07% 198
2022
Q1
$11.6M Hold
23,550
0.93% 25
2021
Q4
$10.9M Buy
+23,550
New +$9.91M 0.84% 28

Other funds holding ELV

Baader Bank Aktiengesellschaft's ELV Position: Q4 2025 in Review

Baader Bank Aktiengesellschaft sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,539 shares — an estimated $487K sold.

Baader Bank Aktiengesellschaft first reported a position in ELV in Q4 2021 and held it in 12 quarters. The position peaked at $11.6M in Q1 2022. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Baader Bank Aktiengesellschaft reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 1,539 Elevance Health shares in Q4 2025, an estimated $487K.
  • Baader Bank Aktiengesellschaft first reported a position in Elevance Health in Q4 2021 and held it in 12 quarters.
  • Baader Bank Aktiengesellschaft's Elevance Health position peaked at $11.6M in Q1 2022.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2025, filed 5 Feb 2026.